位置:首页 > 蛋白库 > SDCB1_HUMAN
SDCB1_HUMAN
ID   SDCB1_HUMAN             Reviewed;         298 AA.
AC   O00560; B2R5Q7; B4DUH3; B7ZLN2; O00173; O43391; Q14CP2;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   03-AUG-2022, entry version 215.
DE   RecName: Full=Syntenin-1;
DE   AltName: Full=Melanoma differentiation-associated protein 9;
DE            Short=MDA-9;
DE   AltName: Full=Pro-TGF-alpha cytoplasmic domain-interacting protein 18;
DE            Short=TACIP18;
DE   AltName: Full=Scaffold protein Pbp1;
DE   AltName: Full=Syndecan-binding protein 1;
GN   Name=SDCBP; Synonyms=MDA9, SYCL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Lin J.J., Jiang H., Fisher P.B.;
RT   "Characterization of a novel melanoma differentiation associated gene, mda-
RT   9, that is down-regulated during terminal cell differentiation.";
RL   Mol. Cell. Differ. 4:317-333(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH SDC2, AND VARIANT
RP   SER-69.
RX   PubMed=9391086; DOI=10.1073/pnas.94.25.13683;
RA   Grootjans J.J., Zimmermann P., Reekmans G., Smets A., Degeest G., Duerr J.,
RA   David G.;
RT   "Syntenin, a PDZ protein that binds syndecan cytoplasmic domains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:13683-13688(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Burbelo P.D.;
RT   "A new family of scaffold proteins.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9511750; DOI=10.1016/s0378-1119(97)00562-3;
RA   Lin J.J., Jiang H., Fisher P.B.;
RT   "Melanoma differentiation associated gene-9, mda-9, is a human gamma
RT   interferon responsive gene.";
RL   Gene 207:105-110(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Rectum, and Urinary bladder;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-14; 218-229 AND 289-298, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT SER-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Pre-B cell;
RA   Bienvenut W.V., Sumpton D.P., Lilla S., Ozanne B.W.;
RL   Submitted (FEB-2009) to UniProtKB.
RN   [10]
RP   INTERACTION WITH EPHB1 AND EPHA7.
RX   PubMed=9883737; DOI=10.1016/s0896-6273(00)80663-7;
RA   Torres R., Firestein B.L., Dong H., Staudinger J., Olson E.N.,
RA   Huganir R.L., Bredt D.S., Gale N.W., Yancopoulos G.D.;
RT   "PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors
RT   and their ephrin ligands.";
RL   Neuron 21:1453-1463(1998).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH TGFA.
RX   PubMed=10230395; DOI=10.1016/s1097-2765(00)80470-0;
RA   Fernandez-Larrea J., Merlos-Suarez A., Urena J.M., Baselga J., Arribas J.;
RT   "A role for a PDZ protein in the early secretory pathway for the targeting
RT   of proTGF-alpha to the cell surface.";
RL   Mol. Cell 3:423-433(1999).
RN   [12]
RP   INTERACTION WITH SYNDECANS; NRXN2 AND EPHB1.
RX   PubMed=10770943; DOI=10.1074/jbc.m002459200;
RA   Grootjans J.J., Reekmans G., Ceulemans H., David G.;
RT   "Syntenin-syndecan binding requires syndecan-synteny and the co-operation
RT   of both PDZ domains of syntenin.";
RL   J. Biol. Chem. 275:19933-19941(2000).
RN   [13]
RP   INTERACTION WITH SDCBP2.
RC   TISSUE=Fetal brain;
RX   PubMed=11152476; DOI=10.1074/jbc.m010647200;
RA   Koroll M., Rathjen F.G., Volkmer H.;
RT   "The neural cell recognition molecule neurofascin interacts with syntenin-1
RT   but not with syntenin-2, both of which reveal self-associating activity.";
RL   J. Biol. Chem. 276:10646-10654(2001).
RN   [14]
RP   INTERACTION WITH NF2.
RX   PubMed=11432873; DOI=10.1074/jbc.m105792200;
RA   Jannatipour M., Dion P., Khan S., Jindal H., Fan X., Laganiere J.,
RA   Chishti A.H., Rouleau G.A.;
RT   "Schwannomin isoform-1 interacts with syntenin via PDZ domains.";
RL   J. Biol. Chem. 276:33093-33100(2001).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11179419; DOI=10.1091/mbc.12.2.339;
RA   Zimmermann P., Tomatis D., Rosas M., Grootjans J.J., Leenaerts I.,
RA   Degeest G., Reekmans G., Coomans C., David G.;
RT   "Characterization of syntenin, a syndecan-binding PDZ protein, as a
RT   component of cell adhesion sites and microfilaments.";
RL   Mol. Biol. Cell 12:339-350(2001).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH IL5RA.
RX   PubMed=11498591; DOI=10.1126/science.1059157;
RA   Geijsen N., Uings I.J., Pals C., Armstrong J., McKinnon M.,
RA   Raaijmakers J.A.M., Lammers J.-W., Koenderman L., Coffer P.J.;
RT   "Cytokine-specific transcriptional regulation through an IL-5Ralpha
RT   interacting protein.";
RL   Science 293:1136-1138(2001).
RN   [17]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K., Valencia J.,
RA   Muller J., Vieira W.D., Watabe H., Shabanowitz J., Hearing V.J., Hunt D.F.,
RA   Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [18]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PDCD6IP.
RX   PubMed=22660413; DOI=10.1038/ncb2502;
RA   Baietti M.F., Zhang Z., Mortier E., Melchior A., Degeest G., Geeraerts A.,
RA   Ivarsson Y., Depoortere F., Coomans C., Vermeiren E., Zimmermann P.,
RA   David G.;
RT   "Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.";
RL   Nat. Cell Biol. 14:677-685(2012).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-46, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   REVIEW.
RX   PubMed=26032692; DOI=10.1111/boc.201500010;
RA   Friand V., David G., Zimmermann P.;
RT   "Syntenin and syndecan in the biogenesis of exosomes.";
RL   Biol. Cell 107:331-341(2015).
RN   [25]
RP   REVIEW.
RX   PubMed=25219541; DOI=10.1517/14728222.2014.959495;
RA   Kegelman T.P., Das S.K., Emdad L., Hu B., Menezes M.E., Bhoopathi P.,
RA   Wang X.Y., Pellecchia M., Sarkar D., Fisher P.B.;
RT   "Targeting tumor invasion: the roles of MDA-9/Syntenin.";
RL   Expert Opin. Ther. Targets 19:97-112(2015).
RN   [26]
RP   FUNCTION.
RX   PubMed=26539120; DOI=10.3389/fphar.2015.00241;
RA   Kashyap R., Roucourt B., Lembo F., Fares J., Carcavilla A.M., Restouin A.,
RA   Zimmermann P., Ghossoub R.;
RT   "Syntenin controls migration, growth, proliferation, and cell cycle
RT   progression in cancer cells.";
RL   Front. Pharmacol. 6:241-241(2015).
RN   [27]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH TGFBR1, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=25893292; DOI=10.1038/onc.2015.100;
RA   Hwangbo C., Tae N., Lee S., Kim O., Park O.K., Kim J., Kwon S.H., Lee J.H.;
RT   "Syntenin regulates TGF-beta1-induced Smad activation and the epithelial-
RT   to-mesenchymal transition by inhibiting caveolin-mediated TGF-beta type I
RT   receptor internalization.";
RL   Oncogene 35:389-401(2016).
RN   [28]
RP   REVIEW, AND FUNCTION.
RX   PubMed=26291527; DOI=10.1002/jcp.25136;
RA   Philley J.V., Kannan A., Dasgupta S.;
RT   "MDA-9/syntenin control.";
RL   J. Cell. Physiol. 231:545-550(2016).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 113-273.
RX   PubMed=12679023; DOI=10.1016/s0969-2126(03)00052-2;
RA   Kang B.S., Cooper D.R., Jelen F., Devedjiev Y., Derewenda U., Dauter Z.,
RA   Otlewski J., Derewenda Z.S.;
RT   "PDZ tandem of human syntenin: crystal structure and functional
RT   properties.";
RL   Structure 11:459-468(2003).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 197-270 IN COMPLEXES WITH IL5RA
RP   AND SDC4.
RX   PubMed=12842047; DOI=10.1016/s0969-2126(03)00125-4;
RA   Kang B.S., Cooper D.R., Devedjiev Y., Derewenda U., Derewenda Z.S.;
RT   "Molecular roots of degenerate specificity in syntenin's PDZ2 domain:
RT   reassessment of the PDZ recognition paradigm.";
RL   Structure 11:845-853(2003).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (0.73 ANGSTROMS) OF 197-273.
RX   PubMed=15081807; DOI=10.1016/j.jmb.2004.02.057;
RA   Kang B.S., Devedjiev Y., Derewenda U., Derewenda Z.S.;
RT   "The PDZ2 domain of syntenin at ultra-high resolution: bridging the gap
RT   between macromolecular and small molecule crystallography.";
RL   J. Mol. Biol. 338:483-493(2004).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (1.56 ANGSTROMS) OF 113-273 IN COMPLEXES WITH
RP   C-TERMINAL PEPTIDES FROM NEUREXIN; EPHB1 AND SDC4.
RX   PubMed=16533050; DOI=10.1021/bi052225y;
RA   Grembecka J., Cierpicki T., Devedjiev Y., Derewenda U., Kang B.S.,
RA   Bushweller J.H., Derewenda Z.S.;
RT   "The binding of the PDZ tandem of syntenin to target proteins.";
RL   Biochemistry 45:3674-3683(2006).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 111-275 IN COMPLEXES WITH
RP   C-TERMINAL PEPTIDES FROM FZD7 AND INOSITOL BISPHOSPHATE, INTERACTION WITH
RP   FZD7, MUTAGENESIS OF LYS-214; ASN-215 AND LYS-250, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=27386966; DOI=10.1038/ncomms12101;
RA   Egea-Jimenez A.L., Gallardo R., Garcia-Pino A., Ivarsson Y.,
RA   Wawrzyniak A.M., Kashyap R., Loris R., Schymkowitz J., Rousseau F.,
RA   Zimmermann P.;
RT   "Frizzled 7 and PIP2 binding by syntenin PDZ2 domain supports Frizzled 7
RT   trafficking and signalling.";
RL   Nat. Commun. 7:12101-12101(2016).
CC   -!- FUNCTION: Multifunctional adapter protein involved in diverse array of
CC       functions including trafficking of transmembrane proteins, neuro and
CC       immunomodulation, exosome biogenesis, and tumorigenesis
CC       (PubMed:26291527). Positively regulates TGFB1-mediated SMAD2/3
CC       activation and TGFB1-induced epithelial-to-mesenchymal transition (EMT)
CC       and cell migration in various cell types. May increase TGFB1 signaling
CC       by enhancing cell-surface expression of TGFR1 by preventing the
CC       interaction between TGFR1 and CAV1 and subsequent CAV1-dependent
CC       internalization and degradation of TGFR1 (PubMed:25893292). In concert
CC       with SDC1/4 and PDCD6IP, regulates exosome biogenesis
CC       (PubMed:22660413). Regulates migration, growth, proliferation, and cell
CC       cycle progression in a variety of cancer types (PubMed:26539120). In
CC       adherens junctions may function to couple syndecans to cytoskeletal
CC       proteins or signaling components. Seems to couple transcription factor
CC       SOX4 to the IL-5 receptor (IL5RA) (PubMed:11498591). May also play a
CC       role in vesicular trafficking (PubMed:11179419). Seems to be required
CC       for the targeting of TGFA to the cell surface in the early secretory
CC       pathway (PubMed:10230395). {ECO:0000269|PubMed:10230395,
CC       ECO:0000269|PubMed:11179419, ECO:0000269|PubMed:11498591,
CC       ECO:0000269|PubMed:22660413, ECO:0000269|PubMed:25893292,
CC       ECO:0000269|PubMed:26539120, ECO:0000303|PubMed:26291527}.
CC   -!- SUBUNIT: Monomer and homodimer (By similarity). Interacts with SDC1,
CC       SDC2, SDC3, SDC4, NRXN2, EPHA7, EPHB1, NF2 isoform 1, TGFA and IL5RA.
CC       Interacts with NFASC and PTPRJ (By similarity). Interacts with SDCBP2
CC       (PubMed:11152476). Interacts with PDCD6IP (PubMed:22660413). Forms a
CC       complex with PDCD6IP and SDC2 (PubMed:22660413). Interacts (via C-
CC       terminus) with TGFBR1 (PubMed:25893292). Binds to FZD7; this
CC       interaction is increased by inositol trisphosphate (IP3)
CC       (PubMed:27386966). Interacts with SMO (By similarity).
CC       {ECO:0000250|UniProtKB:O08992, ECO:0000250|UniProtKB:Q9JI92,
CC       ECO:0000269|PubMed:11152476, ECO:0000269|PubMed:22660413,
CC       ECO:0000269|PubMed:25893292, ECO:0000269|PubMed:27386966}.
CC   -!- INTERACTION:
CC       O00560; Q9NYB9: ABI2; NbExp=5; IntAct=EBI-727004, EBI-743598;
CC       O00560; Q7Z3H0-1: ANKRD33; NbExp=3; IntAct=EBI-727004, EBI-16746154;
CC       O00560; Q8N2N9-4: ANKRD36B; NbExp=3; IntAct=EBI-727004, EBI-12170453;
CC       O00560; Q6AI12: ANKRD40; NbExp=3; IntAct=EBI-727004, EBI-2838246;
CC       O00560; Q92688: ANP32B; NbExp=6; IntAct=EBI-727004, EBI-762428;
CC       O00560; Q96GX9: APIP; NbExp=5; IntAct=EBI-727004, EBI-359248;
CC       O00560; P53365: ARFIP2; NbExp=3; IntAct=EBI-727004, EBI-638194;
CC       O00560; Q15041: ARL6IP1; NbExp=3; IntAct=EBI-727004, EBI-714543;
CC       O00560; P54253: ATXN1; NbExp=6; IntAct=EBI-727004, EBI-930964;
CC       O00560; Q5TBC7: BCL2L15; NbExp=3; IntAct=EBI-727004, EBI-10247136;
CC       O00560; Q8N7W2-2: BEND7; NbExp=3; IntAct=EBI-727004, EBI-10181188;
CC       O00560; Q9H3H3: C11orf68; NbExp=3; IntAct=EBI-727004, EBI-721765;
CC       O00560; Q9H3H3-3: C11orf68; NbExp=3; IntAct=EBI-727004, EBI-12002214;
CC       O00560; Q9NX04: C1orf109; NbExp=3; IntAct=EBI-727004, EBI-8643161;
CC       O00560; O14523: C2CD2L; NbExp=3; IntAct=EBI-727004, EBI-12822627;
CC       O00560; Q9NP86: CABP5; NbExp=3; IntAct=EBI-727004, EBI-10311131;
CC       O00560; A2RRN7: CADPS; NbExp=3; IntAct=EBI-727004, EBI-10179719;
CC       O00560; Q9ULU8-4: CADPS; NbExp=3; IntAct=EBI-727004, EBI-10180690;
CC       O00560; Q13137: CALCOCO2; NbExp=3; IntAct=EBI-727004, EBI-739580;
CC       O00560; P51636: CAV2; NbExp=3; IntAct=EBI-727004, EBI-603607;
CC       O00560; O75828: CBR3; NbExp=8; IntAct=EBI-727004, EBI-714504;
CC       O00560; Q68D86: CCDC102B; NbExp=3; IntAct=EBI-727004, EBI-10171570;
CC       O00560; Q9BWC9: CCDC106; NbExp=3; IntAct=EBI-727004, EBI-711501;
CC       O00560; P32320: CDA; NbExp=6; IntAct=EBI-727004, EBI-9250559;
CC       O00560; P49427: CDC34; NbExp=6; IntAct=EBI-727004, EBI-975634;
CC       O00560; Q9H5V8: CDCP1; NbExp=6; IntAct=EBI-727004, EBI-1019736;
CC       O00560; O14735: CDIPT; NbExp=3; IntAct=EBI-727004, EBI-358858;
CC       O00560; P55273: CDKN2D; NbExp=3; IntAct=EBI-727004, EBI-745859;
CC       O00560; Q53EZ4: CEP55; NbExp=6; IntAct=EBI-727004, EBI-747776;
CC       O00560; Q6P2H3-3: CEP85; NbExp=3; IntAct=EBI-727004, EBI-12368239;
CC       O00560; Q9UFW8: CGGBP1; NbExp=3; IntAct=EBI-727004, EBI-723153;
CC       O00560; Q9UKJ5: CHIC2; NbExp=3; IntAct=EBI-727004, EBI-741528;
CC       O00560; Q9HD42: CHMP1A; NbExp=3; IntAct=EBI-727004, EBI-1057156;
CC       O00560; P49760: CLK2; NbExp=3; IntAct=EBI-727004, EBI-750020;
CC       O00560; P49761: CLK3; NbExp=6; IntAct=EBI-727004, EBI-745579;
CC       O00560; Q96DZ9: CMTM5; NbExp=3; IntAct=EBI-727004, EBI-2548702;
CC       O00560; Q96DZ9-2: CMTM5; NbExp=3; IntAct=EBI-727004, EBI-11522780;
CC       O00560; P13073: COX4I1; NbExp=4; IntAct=EBI-727004, EBI-1056574;
CC       O00560; Q86WV2: COX4I1; NbExp=3; IntAct=EBI-727004, EBI-10260134;
CC       O00560; O43186: CRX; NbExp=3; IntAct=EBI-727004, EBI-748171;
CC       O00560; P02489: CRYAA; NbExp=7; IntAct=EBI-727004, EBI-6875961;
CC       O00560; Q5HYN5: CT45A1; NbExp=3; IntAct=EBI-727004, EBI-12051833;
CC       O00560; P0DMU9: CT45A10; NbExp=6; IntAct=EBI-727004, EBI-12153495;
CC       O00560; Q8NHU0: CT45A3; NbExp=9; IntAct=EBI-727004, EBI-8643558;
CC       O00560; Q6NSH3: CT45A5; NbExp=3; IntAct=EBI-727004, EBI-8635816;
CC       O00560; P56545-3: CTBP2; NbExp=3; IntAct=EBI-727004, EBI-10171902;
CC       O00560; Q9GZU7: CTDSP1; NbExp=3; IntAct=EBI-727004, EBI-751587;
CC       O00560; Q9NTM9: CUTC; NbExp=6; IntAct=EBI-727004, EBI-714918;
CC       O00560; Q6ZMK1-3: CYHR1; NbExp=3; IntAct=EBI-727004, EBI-11997340;
CC       O00560; P32321: DCTD; NbExp=6; IntAct=EBI-727004, EBI-739870;
CC       O00560; Q9H773: DCTPP1; NbExp=3; IntAct=EBI-727004, EBI-723569;
CC       O00560; Q13838: DDX39B; NbExp=3; IntAct=EBI-727004, EBI-348622;
CC       O00560; Q96Q80: DERL3; NbExp=3; IntAct=EBI-727004, EBI-12831318;
CC       O00560; Q14565: DMC1; NbExp=7; IntAct=EBI-727004, EBI-930865;
CC       O00560; G5E9A7: DMWD; NbExp=3; IntAct=EBI-727004, EBI-10976677;
CC       O00560; P50570: DNM2; NbExp=3; IntAct=EBI-727004, EBI-346547;
CC       O00560; Q14919: DRAP1; NbExp=5; IntAct=EBI-727004, EBI-712941;
CC       O00560; Q96EV8: DTNBP1; NbExp=3; IntAct=EBI-727004, EBI-465804;
CC       O00560; P63172: DYNLT1; NbExp=3; IntAct=EBI-727004, EBI-1176455;
CC       O00560; Q96JC9: EAF1; NbExp=3; IntAct=EBI-727004, EBI-769261;
CC       O00560; Q8WWZ3: EDARADD; NbExp=3; IntAct=EBI-727004, EBI-2949647;
CC       O00560; Q8N9N8: EIF1AD; NbExp=6; IntAct=EBI-727004, EBI-750700;
CC       O00560; P63241: EIF5A; NbExp=3; IntAct=EBI-727004, EBI-373150;
CC       O00560; Q9GZV4: EIF5A2; NbExp=6; IntAct=EBI-727004, EBI-748028;
CC       O00560; Q15717: ELAVL1; NbExp=3; IntAct=EBI-727004, EBI-374260;
CC       O00560; Q9NT22: EMILIN3; NbExp=3; IntAct=EBI-727004, EBI-3197883;
CC       O00560; Q8TC92: ENOX1; NbExp=3; IntAct=EBI-727004, EBI-713221;
CC       O00560; Q96C92-2: ENTR1; NbExp=3; IntAct=EBI-727004, EBI-10178036;
CC       O00560; A1L162: ERICH2; NbExp=3; IntAct=EBI-727004, EBI-2682520;
CC       O00560; Q9NPD3: EXOSC4; NbExp=3; IntAct=EBI-727004, EBI-371823;
CC       O00560; Q13158: FADD; NbExp=6; IntAct=EBI-727004, EBI-494804;
CC       O00560; Q9NWS6: FAM118A; NbExp=3; IntAct=EBI-727004, EBI-8638992;
CC       O00560; Q9BPY3: FAM118B; NbExp=3; IntAct=EBI-727004, EBI-726822;
CC       O00560; Q8IZU1: FAM9A; NbExp=3; IntAct=EBI-727004, EBI-8468186;
CC       O00560; Q8IZU0: FAM9B; NbExp=6; IntAct=EBI-727004, EBI-10175124;
CC       O00560; Q13643: FHL3; NbExp=3; IntAct=EBI-727004, EBI-741101;
CC       O00560; Q5TD97: FHL5; NbExp=3; IntAct=EBI-727004, EBI-750641;
CC       O00560; Q8NFF5: FLAD1; NbExp=4; IntAct=EBI-727004, EBI-742815;
CC       O00560; O15409: FOXP2; NbExp=3; IntAct=EBI-727004, EBI-983612;
CC       O00560; Q6NZ44: FTH1; NbExp=3; IntAct=EBI-727004, EBI-10180219;
CC       O00560; P02792: FTL; NbExp=6; IntAct=EBI-727004, EBI-713279;
CC       O00560; O75084: FZD7; NbExp=4; IntAct=EBI-727004, EBI-746917;
CC       O00560; Q7L5D6: GET4; NbExp=3; IntAct=EBI-727004, EBI-711823;
CC       O00560; O95749: GGPS1; NbExp=3; IntAct=EBI-727004, EBI-10179283;
CC       O00560; Q5VSY0: GKAP1; NbExp=3; IntAct=EBI-727004, EBI-743722;
CC       O00560; Q9Y3E0: GOLT1B; NbExp=3; IntAct=EBI-727004, EBI-4402607;
CC       O00560; Q8N954: GPATCH11; NbExp=3; IntAct=EBI-727004, EBI-2555378;
CC       O00560; Q8N954-2: GPATCH11; NbExp=3; IntAct=EBI-727004, EBI-12178961;
CC       O00560; A8MXD5: GRXCR1; NbExp=3; IntAct=EBI-727004, EBI-5235612;
CC       O00560; O15499: GSC2; NbExp=3; IntAct=EBI-727004, EBI-19954058;
CC       O00560; Q2KHT4-3: GSG1; NbExp=3; IntAct=EBI-727004, EBI-12951679;
CC       O00560; A0A024RA76: hCG_1744368; NbExp=5; IntAct=EBI-727004, EBI-10180729;
CC       O00560; V9HW60: HEL-S-182mP; NbExp=3; IntAct=EBI-727004, EBI-10180762;
CC       O00560; V9HW40: HEL-S-25; NbExp=3; IntAct=EBI-727004, EBI-10330099;
CC       O00560; Q96MH2: HEXIM2; NbExp=3; IntAct=EBI-727004, EBI-5460660;
CC       O00560; Q5VTY9: HHAT; NbExp=3; IntAct=EBI-727004, EBI-12951255;
CC       O00560; Q6NT76: HMBOX1; NbExp=3; IntAct=EBI-727004, EBI-2549423;
CC       O00560; O15347: HMGB3; NbExp=7; IntAct=EBI-727004, EBI-2214136;
CC       O00560; P07910: HNRNPC; NbExp=6; IntAct=EBI-727004, EBI-357966;
CC       O00560; Q9NSC5: HOMER3; NbExp=5; IntAct=EBI-727004, EBI-748420;
CC       O00560; Q8IX15-3: HOMEZ; NbExp=3; IntAct=EBI-727004, EBI-10172004;
CC       O00560; P49639: HOXA1; NbExp=6; IntAct=EBI-727004, EBI-740785;
CC       O00560; P31268: HOXA7; NbExp=3; IntAct=EBI-727004, EBI-3910421;
CC       O00560; P00492: HPRT1; NbExp=7; IntAct=EBI-727004, EBI-748210;
CC       O00560; O75506: HSBP1; NbExp=8; IntAct=EBI-727004, EBI-748664;
CC       O00560; O75031: HSF2BP; NbExp=3; IntAct=EBI-727004, EBI-7116203;
CC       O00560; P42858: HTT; NbExp=12; IntAct=EBI-727004, EBI-466029;
CC       O00560; O60921: HUS1; NbExp=3; IntAct=EBI-727004, EBI-1056174;
CC       O00560; Q02535: ID3; NbExp=3; IntAct=EBI-727004, EBI-1387094;
CC       O00560; P24592: IGFBP6; NbExp=3; IntAct=EBI-727004, EBI-947015;
CC       O00560; Q8IYA8: IHO1; NbExp=3; IntAct=EBI-727004, EBI-8638439;
CC       O00560; Q13422: IKZF1; NbExp=3; IntAct=EBI-727004, EBI-745305;
CC       O00560; Q01344: IL5RA; NbExp=2; IntAct=EBI-727004, EBI-1759442;
CC       O00560; Q8NBZ0: INO80E; NbExp=6; IntAct=EBI-727004, EBI-769401;
CC       O00560; Q9H079: KATNBL1; NbExp=3; IntAct=EBI-727004, EBI-715394;
CC       O00560; O95259: KCNH1; NbExp=3; IntAct=EBI-727004, EBI-2909270;
CC       O00560; P63252: KCNJ2; NbExp=3; IntAct=EBI-727004, EBI-703457;
CC       O00560; Q719H9: KCTD1; NbExp=6; IntAct=EBI-727004, EBI-9027502;
CC       O00560; Q8NC69: KCTD6; NbExp=6; IntAct=EBI-727004, EBI-2511344;
CC       O00560; Q7L273: KCTD9; NbExp=6; IntAct=EBI-727004, EBI-4397613;
CC       O00560; Q5VWX1: KHDRBS2; NbExp=6; IntAct=EBI-727004, EBI-742808;
CC       O00560; O60333-2: KIF1B; NbExp=3; IntAct=EBI-727004, EBI-10975473;
CC       O00560; Q53G59: KLHL12; NbExp=8; IntAct=EBI-727004, EBI-740929;
CC       O00560; O95198: KLHL2; NbExp=3; IntAct=EBI-727004, EBI-746999;
CC       O00560; P02533: KRT14; NbExp=3; IntAct=EBI-727004, EBI-702178;
CC       O00560; Q8IUG1: KRTAP1-3; NbExp=3; IntAct=EBI-727004, EBI-11749135;
CC       O00560; Q9BYS1: KRTAP1-5; NbExp=3; IntAct=EBI-727004, EBI-11741292;
CC       O00560; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-727004, EBI-10172290;
CC       O00560; P26371: KRTAP5-9; NbExp=6; IntAct=EBI-727004, EBI-3958099;
CC       O00560; O43679: LDB2; NbExp=3; IntAct=EBI-727004, EBI-2865580;
CC       O00560; P07195: LDHB; NbExp=3; IntAct=EBI-727004, EBI-358748;
CC       O00560; O95751: LDOC1; NbExp=6; IntAct=EBI-727004, EBI-740738;
CC       O00560; O95214: LEPROTL1; NbExp=3; IntAct=EBI-727004, EBI-750776;
CC       O00560; P05162: LGALS2; NbExp=9; IntAct=EBI-727004, EBI-7181544;
CC       O00560; P62312: LSM6; NbExp=6; IntAct=EBI-727004, EBI-373310;
CC       O00560; Q8IV03: LURAP1L; NbExp=3; IntAct=EBI-727004, EBI-12898559;
CC       O00560; Q9NQ48: LZTFL1; NbExp=6; IntAct=EBI-727004, EBI-2824799;
CC       O00560; Q13257: MAD2L1; NbExp=3; IntAct=EBI-727004, EBI-78203;
CC       O00560; P45984: MAPK9; NbExp=3; IntAct=EBI-727004, EBI-713568;
CC       O00560; Q9UPY8: MAPRE3; NbExp=6; IntAct=EBI-727004, EBI-726739;
CC       O00560; O95460-2: MATN4; NbExp=3; IntAct=EBI-727004, EBI-12072296;
CC       O00560; O95983: MBD3; NbExp=3; IntAct=EBI-727004, EBI-1783068;
CC       O00560; Q9NPJ6: MED4; NbExp=3; IntAct=EBI-727004, EBI-394607;
CC       O00560; P50221: MEOX1; NbExp=3; IntAct=EBI-727004, EBI-2864512;
CC       O00560; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-727004, EBI-16439278;
CC       O00560; A0A0C4DFN3: MGLL; NbExp=3; IntAct=EBI-727004, EBI-12866138;
CC       O00560; Q9UJV3-2: MID2; NbExp=3; IntAct=EBI-727004, EBI-10172526;
CC       O00560; Q9H8M7: MINDY3; NbExp=3; IntAct=EBI-727004, EBI-724928;
CC       O00560; Q9UHC7: MKRN1; NbExp=3; IntAct=EBI-727004, EBI-373524;
CC       O00560; Q9BU76: MMTAG2; NbExp=3; IntAct=EBI-727004, EBI-742459;
CC       O00560; Q13875-3: MOBP; NbExp=3; IntAct=EBI-727004, EBI-12013470;
CC       O00560; Q9Y605: MRFAP1; NbExp=3; IntAct=EBI-727004, EBI-995714;
CC       O00560; Q96HT8: MRFAP1L1; NbExp=8; IntAct=EBI-727004, EBI-748896;
CC       O00560; Q5JR59: MTUS2; NbExp=3; IntAct=EBI-727004, EBI-742948;
CC       O00560; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-727004, EBI-11522433;
CC       O00560; Q8WY64: MYLIP; NbExp=3; IntAct=EBI-727004, EBI-6952711;
CC       O00560; O15049: N4BP3; NbExp=3; IntAct=EBI-727004, EBI-2512055;
CC       O00560; O95544: NADK; NbExp=7; IntAct=EBI-727004, EBI-743949;
CC       O00560; Q9UJ70: NAGK; NbExp=5; IntAct=EBI-727004, EBI-372578;
CC       O00560; Q9UJ70-2: NAGK; NbExp=3; IntAct=EBI-727004, EBI-11526455;
CC       O00560; Q9H115: NAPB; NbExp=3; IntAct=EBI-727004, EBI-3921185;
CC       O00560; Q7Z6G3-2: NECAB2; NbExp=5; IntAct=EBI-727004, EBI-10172876;
CC       O00560; Q15223: NECTIN1; NbExp=8; IntAct=EBI-727004, EBI-1771314;
CC       O00560; Q6ZUT1: NKAPD1; NbExp=8; IntAct=EBI-727004, EBI-3920396;
CC       O00560; Q6ZUT1-2: NKAPD1; NbExp=3; IntAct=EBI-727004, EBI-10180231;
CC       O00560; Q7Z3S9: NOTCH2NLA; NbExp=3; IntAct=EBI-727004, EBI-945833;
CC       O00560; P49902: NT5C2; NbExp=3; IntAct=EBI-727004, EBI-742084;
CC       O00560; P0CE72: OCM; NbExp=3; IntAct=EBI-727004, EBI-11955379;
CC       O00560; A1E959: ODAM; NbExp=3; IntAct=EBI-727004, EBI-5774125;
CC       O00560; Q96CV9: OPTN; NbExp=3; IntAct=EBI-727004, EBI-748974;
CC       O00560; Q92882: OSTF1; NbExp=3; IntAct=EBI-727004, EBI-1051152;
CC       O00560; P61457: PCBD1; NbExp=3; IntAct=EBI-727004, EBI-740475;
CC       O00560; P49585: PCYT1A; NbExp=3; IntAct=EBI-727004, EBI-2563309;
CC       O00560; Q5VU43: PDE4DIP; NbExp=4; IntAct=EBI-727004, EBI-1105124;
CC       O00560; Q5VU43-2: PDE4DIP; NbExp=4; IntAct=EBI-727004, EBI-9640281;
CC       O00560; O76083-2: PDE9A; NbExp=3; IntAct=EBI-727004, EBI-11524542;
CC       O00560; P50479: PDLIM4; NbExp=3; IntAct=EBI-727004, EBI-372861;
CC       O00560; Q13113: PDZK1IP1; NbExp=3; IntAct=EBI-727004, EBI-716063;
CC       O00560; Q99471: PFDN5; NbExp=3; IntAct=EBI-727004, EBI-357275;
CC       O00560; Q8IXK0: PHC2; NbExp=3; IntAct=EBI-727004, EBI-713786;
CC       O00560; Q9UIL8: PHF11; NbExp=3; IntAct=EBI-727004, EBI-2861403;
CC       O00560; Q8WWB5: PIH1D2; NbExp=3; IntAct=EBI-727004, EBI-10232538;
CC       O00560; Q8ND90: PNMA1; NbExp=8; IntAct=EBI-727004, EBI-302345;
CC       O00560; Q9UL42: PNMA2; NbExp=7; IntAct=EBI-727004, EBI-302355;
CC       O00560; P52435: POLR2J; NbExp=3; IntAct=EBI-727004, EBI-394753;
CC       O00560; Q9Y2Y1: POLR3K; NbExp=3; IntAct=EBI-727004, EBI-11023785;
CC       O00560; Q8NAV1: PRPF38A; NbExp=3; IntAct=EBI-727004, EBI-715374;
CC       O00560; O75400-2: PRPF40A; NbExp=3; IntAct=EBI-727004, EBI-5280197;
CC       O00560; Q9NZ81: PRR13; NbExp=3; IntAct=EBI-727004, EBI-740924;
CC       O00560; P49720: PSMB3; NbExp=3; IntAct=EBI-727004, EBI-603340;
CC       O00560; P62333: PSMC6; NbExp=6; IntAct=EBI-727004, EBI-357669;
CC       O00560; Q9UL46: PSME2; NbExp=3; IntAct=EBI-727004, EBI-741630;
CC       O00560; O43586: PSTPIP1; NbExp=3; IntAct=EBI-727004, EBI-1050964;
CC       O00560; Q03393: PTS; NbExp=4; IntAct=EBI-727004, EBI-712344;
CC       O00560; Q9UHX1: PUF60; NbExp=3; IntAct=EBI-727004, EBI-1053259;
CC       O00560; Q53H96: PYCR3; NbExp=8; IntAct=EBI-727004, EBI-2959680;
CC       O00560; Q53GL6: RALY; NbExp=3; IntAct=EBI-727004, EBI-9512693;
CC       O00560; Q14498: RBM39; NbExp=3; IntAct=EBI-727004, EBI-395290;
CC       O00560; Q96HR9: REEP6; NbExp=3; IntAct=EBI-727004, EBI-750345;
CC       O00560; Q96HR9-2: REEP6; NbExp=3; IntAct=EBI-727004, EBI-14065960;
CC       O00560; Q04864: REL; NbExp=3; IntAct=EBI-727004, EBI-307352;
CC       O00560; Q9NPQ8-4: RIC8A; NbExp=3; IntAct=EBI-727004, EBI-9091816;
CC       O00560; Q9Y3C5: RNF11; NbExp=3; IntAct=EBI-727004, EBI-396669;
CC       O00560; P13489: RNH1; NbExp=8; IntAct=EBI-727004, EBI-1237106;
CC       O00560; Q9HAT0: ROPN1; NbExp=6; IntAct=EBI-727004, EBI-1378139;
CC       O00560; Q8TA86: RP9; NbExp=5; IntAct=EBI-727004, EBI-630339;
CC       O00560; P49247: RPIA; NbExp=3; IntAct=EBI-727004, EBI-744831;
CC       O00560; P35268: RPL22; NbExp=5; IntAct=EBI-727004, EBI-354533;
CC       O00560; Q96P16-3: RPRD1A; NbExp=3; IntAct=EBI-727004, EBI-12840198;
CC       O00560; Q9NS64: RPRM; NbExp=3; IntAct=EBI-727004, EBI-1052363;
CC       O00560; P62854: RPS26; NbExp=3; IntAct=EBI-727004, EBI-353438;
CC       O00560; P31350: RRM2; NbExp=3; IntAct=EBI-727004, EBI-2339245;
CC       O00560; Q15050: RRS1; NbExp=3; IntAct=EBI-727004, EBI-749186;
CC       O00560; Q17RB0: RTL8B; NbExp=3; IntAct=EBI-727004, EBI-10238588;
CC       O00560; Q16799-3: RTN1; NbExp=3; IntAct=EBI-727004, EBI-10180131;
CC       O00560; Q59EK9: RUNDC3A; NbExp=3; IntAct=EBI-727004, EBI-747225;
CC       O00560; Q59EK9-3: RUNDC3A; NbExp=3; IntAct=EBI-727004, EBI-11957366;
CC       O00560; P04271: S100B; NbExp=3; IntAct=EBI-727004, EBI-458391;
CC       O00560; Q8WXD2: SCG3; NbExp=3; IntAct=EBI-727004, EBI-12162999;
CC       O00560; Q9UN30-2: SCML1; NbExp=3; IntAct=EBI-727004, EBI-12137487;
CC       O00560; O00560: SDCBP; NbExp=7; IntAct=EBI-727004, EBI-727004;
CC       O00560; Q8WYJ6: SEPTIN1; NbExp=3; IntAct=EBI-727004, EBI-693002;
CC       O00560; Q9UH03: SEPTIN3; NbExp=6; IntAct=EBI-727004, EBI-727037;
CC       O00560; Q01105: SET; NbExp=3; IntAct=EBI-727004, EBI-1053182;
CC       O00560; Q01105-2: SET; NbExp=3; IntAct=EBI-727004, EBI-7481343;
CC       O00560; Q8WV19: SFT2D1; NbExp=3; IntAct=EBI-727004, EBI-2854842;
CC       O00560; Q8IUQ4: SIAH1; NbExp=3; IntAct=EBI-727004, EBI-747107;
CC       O00560; Q9BRV3: SLC50A1; NbExp=3; IntAct=EBI-727004, EBI-8634123;
CC       O00560; P51531: SMARCA2; NbExp=2; IntAct=EBI-727004, EBI-679562;
CC       O00560; P51531-2: SMARCA2; NbExp=3; IntAct=EBI-727004, EBI-10212306;
CC       O00560; P37840: SNCA; NbExp=3; IntAct=EBI-727004, EBI-985879;
CC       O00560; P09012: SNRPA; NbExp=3; IntAct=EBI-727004, EBI-607085;
CC       O00560; Q13596: SNX1; NbExp=3; IntAct=EBI-727004, EBI-2822329;
CC       O00560; Q5MJ09: SPANXN3; NbExp=3; IntAct=EBI-727004, EBI-12037215;
CC       O00560; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-727004, EBI-5235340;
CC       O00560; P12931: SRC; NbExp=2; IntAct=EBI-727004, EBI-621482;
CC       O00560; Q8N9Q2: SREK1IP1; NbExp=6; IntAct=EBI-727004, EBI-10268630;
CC       O00560; Q05519: SRSF11; NbExp=3; IntAct=EBI-727004, EBI-1051785;
CC       O00560; Q05519-2: SRSF11; NbExp=3; IntAct=EBI-727004, EBI-11975029;
CC       O00560; P84103: SRSF3; NbExp=3; IntAct=EBI-727004, EBI-372557;
CC       O00560; Q16629: SRSF7; NbExp=6; IntAct=EBI-727004, EBI-398885;
CC       O00560; A1L4H1: SSC5D; NbExp=3; IntAct=EBI-727004, EBI-10172867;
CC       O00560; O43805: SSNA1; NbExp=6; IntAct=EBI-727004, EBI-2515299;
CC       O00560; P53999: SUB1; NbExp=3; IntAct=EBI-727004, EBI-998260;
CC       O00560; O43704: SULT1B1; NbExp=3; IntAct=EBI-727004, EBI-10179062;
CC       O00560; O43759-2: SYNGR1; NbExp=3; IntAct=EBI-727004, EBI-12187159;
CC       O00560; Q16563: SYPL1; NbExp=3; IntAct=EBI-727004, EBI-2800683;
CC       O00560; Q8N2H4: SYS1; NbExp=3; IntAct=EBI-727004, EBI-13075176;
CC       O00560; O43680: TCF21; NbExp=3; IntAct=EBI-727004, EBI-723267;
CC       O00560; P15884-3: TCF4; NbExp=3; IntAct=EBI-727004, EBI-13636688;
CC       O00560; P48775: TDO2; NbExp=7; IntAct=EBI-727004, EBI-743494;
CC       O00560; Q969V4: TEKT1; NbExp=3; IntAct=EBI-727004, EBI-10180409;
CC       O00560; Q12800: TFCP2; NbExp=3; IntAct=EBI-727004, EBI-717422;
CC       O00560; Q9NWX6: THG1L; NbExp=3; IntAct=EBI-727004, EBI-746510;
CC       O00560; Q96CG3: TIFA; NbExp=8; IntAct=EBI-727004, EBI-740711;
CC       O00560; Q3LXA3: TKFC; NbExp=3; IntAct=EBI-727004, EBI-4291069;
CC       O00560; Q08117: TLE5; NbExp=3; IntAct=EBI-727004, EBI-717810;
CC       O00560; Q7Z6W1: TMCO2; NbExp=3; IntAct=EBI-727004, EBI-12807858;
CC       O00560; Q86X19: TMEM17; NbExp=3; IntAct=EBI-727004, EBI-11343485;
CC       O00560; Q8WW34: TMEM239; NbExp=3; IntAct=EBI-727004, EBI-9675724;
CC       O00560; Q8WW34-2: TMEM239; NbExp=3; IntAct=EBI-727004, EBI-11528917;
CC       O00560; O95379: TNFAIP8; NbExp=6; IntAct=EBI-727004, EBI-1049336;
CC       O00560; Q5GJ75: TNFAIP8L3; NbExp=3; IntAct=EBI-727004, EBI-14222571;
CC       O00560; O95271: TNKS; NbExp=5; IntAct=EBI-727004, EBI-1105254;
CC       O00560; O00463: TRAF5; NbExp=8; IntAct=EBI-727004, EBI-523498;
CC       O00560; P14373: TRIM27; NbExp=3; IntAct=EBI-727004, EBI-719493;
CC       O00560; Q13049: TRIM32; NbExp=7; IntAct=EBI-727004, EBI-742790;
CC       O00560; O00635: TRIM38; NbExp=3; IntAct=EBI-727004, EBI-2130415;
CC       O00560; Q9BYV2: TRIM54; NbExp=6; IntAct=EBI-727004, EBI-2130429;
CC       O00560; Q15645: TRIP13; NbExp=3; IntAct=EBI-727004, EBI-358993;
CC       O00560; Q86WV8: TSC1; NbExp=3; IntAct=EBI-727004, EBI-12806590;
CC       O00560; Q15631: TSN; NbExp=3; IntAct=EBI-727004, EBI-1044160;
CC       O00560; A5PKU2: TUSC5; NbExp=3; IntAct=EBI-727004, EBI-11988865;
CC       O00560; P0CG47: UBB; NbExp=3; IntAct=EBI-727004, EBI-413034;
CC       O00560; P49459: UBE2A; NbExp=9; IntAct=EBI-727004, EBI-2339348;
CC       O00560; P61086: UBE2K; NbExp=3; IntAct=EBI-727004, EBI-473850;
CC       O00560; Q712K3: UBE2R2; NbExp=3; IntAct=EBI-727004, EBI-2340879;
CC       O00560; O95292: VAPB; NbExp=3; IntAct=EBI-727004, EBI-1188298;
CC       O00560; Q9Y3C0: WASHC3; NbExp=6; IntAct=EBI-727004, EBI-712969;
CC       O00560; O00401: WASL; NbExp=6; IntAct=EBI-727004, EBI-957615;
CC       O00560; O76024: WFS1; NbExp=3; IntAct=EBI-727004, EBI-720609;
CC       O00560; O95070: YIF1A; NbExp=3; IntAct=EBI-727004, EBI-2799703;
CC       O00560; O43829: ZBTB14; NbExp=3; IntAct=EBI-727004, EBI-10176632;
CC       O00560; Q96BR9: ZBTB8A; NbExp=6; IntAct=EBI-727004, EBI-742740;
CC       O00560; Q8TBK6: ZCCHC10; NbExp=3; IntAct=EBI-727004, EBI-597063;
CC       O00560; Q9NP64: ZCCHC17; NbExp=8; IntAct=EBI-727004, EBI-746345;
CC       O00560; Q9H0C1: ZMYND12; NbExp=3; IntAct=EBI-727004, EBI-12030590;
CC       O00560; Q6P1L6: ZNF343; NbExp=3; IntAct=EBI-727004, EBI-10252492;
CC       O00560; Q8NCK3: ZNF485; NbExp=3; IntAct=EBI-727004, EBI-12901093;
CC       O00560; Q6AZW8: ZNF660; NbExp=3; IntAct=EBI-727004, EBI-12376497;
CC       O00560; Q9H5H4: ZNF768; NbExp=3; IntAct=EBI-727004, EBI-1210580;
CC       O00560; Q9UGI0: ZRANB1; NbExp=3; IntAct=EBI-727004, EBI-527853;
CC       O00560; Q3MJ62: ZSCAN23; NbExp=3; IntAct=EBI-727004, EBI-5667532;
CC       O00560-1; P59637: E; Xeno; NbExp=4; IntAct=EBI-9640690, EBI-25487741;
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:11179419}. Cell junction, adherens junction
CC       {ECO:0000269|PubMed:11179419}. Cell membrane
CC       {ECO:0000269|PubMed:11179419, ECO:0000269|PubMed:25893292,
CC       ECO:0000269|PubMed:27386966}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:11179419, ECO:0000269|PubMed:27386966}. Endoplasmic
CC       reticulum membrane {ECO:0000269|PubMed:17081065}; Peripheral membrane
CC       protein {ECO:0000269|PubMed:17081065}. Nucleus
CC       {ECO:0000269|PubMed:11179419}. Melanosome {ECO:0000269|PubMed:12643545,
CC       ECO:0000269|PubMed:17081065}. Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:11179419}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:11179419}. Secreted, extracellular exosome
CC       {ECO:0000269|PubMed:22660413}. Membrane raft
CC       {ECO:0000269|PubMed:25893292}. Note=Mainly membrane-associated.
CC       Localized to adherens junctions, focal adhesions and endoplasmic
CC       reticulum. Colocalized with actin stress fibers. Also found in the
CC       nucleus. Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV. Associated to the plasma membrane in the presence
CC       of FZD7 and phosphatidylinositol 4,5-bisphosphate (PIP2)
CC       (PubMed:27386966). {ECO:0000269|PubMed:11179419,
CC       ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065,
CC       ECO:0000269|PubMed:27386966}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O00560-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00560-2; Sequence=VSP_038375;
CC       Name=3;
CC         IsoId=O00560-3; Sequence=VSP_038374;
CC   -!- TISSUE SPECIFICITY: Expressed in lung cancers, including
CC       adenocarcinoma, squamous cell carcinoma and small-cell carcinoma (at
CC       protein level) (PubMed:25893292). Widely expressed. Expressed in fetal
CC       kidney, liver, lung and brain. In adult highest expression in heart and
CC       placenta. {ECO:0000269|PubMed:25893292}.
CC   -!- INDUCTION: By IFNG/IFN-gamma in melanoma cells.
CC   -!- PTM: Phosphorylated on tyrosine residues.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SDCBPID44377ch8q12.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF006636; AAC52050.1; -; mRNA.
DR   EMBL; AF000652; AAB97144.1; -; mRNA.
DR   EMBL; U83463; AAB51246.1; -; mRNA.
DR   EMBL; AK300647; BAG62335.1; -; mRNA.
DR   EMBL; AK312274; BAG35204.1; -; mRNA.
DR   EMBL; AC068522; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471068; EAW86814.1; -; Genomic_DNA.
DR   EMBL; BC113674; AAI13675.1; -; mRNA.
DR   EMBL; BC113676; AAI13677.1; -; mRNA.
DR   EMBL; BC143915; AAI43916.1; -; mRNA.
DR   EMBL; BC143916; AAI43917.1; -; mRNA.
DR   CCDS; CCDS47862.1; -. [O00560-2]
DR   CCDS; CCDS47863.1; -. [O00560-3]
DR   CCDS; CCDS6172.1; -. [O00560-1]
DR   PIR; JC6537; JC6537.
DR   RefSeq; NP_001007068.1; NM_001007067.1. [O00560-1]
DR   RefSeq; NP_001007069.1; NM_001007068.1. [O00560-3]
DR   RefSeq; NP_001007070.1; NM_001007069.1. [O00560-2]
DR   RefSeq; NP_001007071.1; NM_001007070.1. [O00560-2]
DR   RefSeq; NP_005616.2; NM_005625.3. [O00560-1]
DR   PDB; 1N99; X-ray; 1.94 A; A/B=113-273.
DR   PDB; 1NTE; X-ray; 1.24 A; A=197-273.
DR   PDB; 1OBX; X-ray; 1.35 A; A=197-270.
DR   PDB; 1OBY; X-ray; 1.85 A; A/B=197-270.
DR   PDB; 1OBZ; X-ray; 1.69 A; A/B=113-273.
DR   PDB; 1R6J; X-ray; 0.73 A; A=197-273.
DR   PDB; 1V1T; X-ray; 1.80 A; A/B=113-273.
DR   PDB; 1W9E; X-ray; 1.56 A; A/B=113-273.
DR   PDB; 1W9O; X-ray; 2.25 A; A/B=113-273.
DR   PDB; 1W9Q; X-ray; 1.70 A; A/B=113-273.
DR   PDB; 1YBO; X-ray; 2.30 A; A/B=113-273.
DR   PDB; 4Z33; X-ray; 2.45 A; A/B=111-275.
DR   PDB; 6R9H; X-ray; 2.00 A; A/B/C/D=113-273.
DR   PDB; 6RLC; X-ray; 2.20 A; A/B/C/D=113-273.
DR   PDBsum; 1N99; -.
DR   PDBsum; 1NTE; -.
DR   PDBsum; 1OBX; -.
DR   PDBsum; 1OBY; -.
DR   PDBsum; 1OBZ; -.
DR   PDBsum; 1R6J; -.
DR   PDBsum; 1V1T; -.
DR   PDBsum; 1W9E; -.
DR   PDBsum; 1W9O; -.
DR   PDBsum; 1W9Q; -.
DR   PDBsum; 1YBO; -.
DR   PDBsum; 4Z33; -.
DR   PDBsum; 6R9H; -.
DR   PDBsum; 6RLC; -.
DR   AlphaFoldDB; O00560; -.
DR   SMR; O00560; -.
DR   BioGRID; 112287; 418.
DR   ComplexPortal; CPX-3282; Syndecan-1-syntenin-1-ALIX complex.
DR   DIP; DIP-42705N; -.
DR   IntAct; O00560; 403.
DR   MINT; O00560; -.
DR   STRING; 9606.ENSP00000260130; -.
DR   BindingDB; O00560; -.
DR   ChEMBL; CHEMBL4739667; -.
DR   MoonDB; O00560; Predicted.
DR   TCDB; 8.A.24.2.1; the ezrin/radixin/moesin-binding phosphoprotein 50 (ebp50) family.
DR   GlyGen; O00560; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O00560; -.
DR   PhosphoSitePlus; O00560; -.
DR   SwissPalm; O00560; -.
DR   BioMuta; SDCBP; -.
DR   EPD; O00560; -.
DR   jPOST; O00560; -.
DR   MassIVE; O00560; -.
DR   MaxQB; O00560; -.
DR   PaxDb; O00560; -.
DR   PeptideAtlas; O00560; -.
DR   PRIDE; O00560; -.
DR   ProteomicsDB; 47974; -. [O00560-1]
DR   ProteomicsDB; 47975; -. [O00560-2]
DR   ProteomicsDB; 47976; -. [O00560-3]
DR   TopDownProteomics; O00560-1; -. [O00560-1]
DR   Antibodypedia; 3216; 535 antibodies from 38 providers.
DR   DNASU; 6386; -.
DR   Ensembl; ENST00000260130.9; ENSP00000260130.4; ENSG00000137575.12. [O00560-1]
DR   Ensembl; ENST00000413219.6; ENSP00000411771.2; ENSG00000137575.12. [O00560-1]
DR   Ensembl; ENST00000424270.6; ENSP00000395351.2; ENSG00000137575.12. [O00560-3]
DR   Ensembl; ENST00000447182.6; ENSP00000409288.2; ENSG00000137575.12. [O00560-2]
DR   GeneID; 6386; -.
DR   KEGG; hsa:6386; -.
DR   MANE-Select; ENST00000260130.9; ENSP00000260130.4; NM_005625.4; NP_005616.2.
DR   UCSC; uc003xtn.3; human. [O00560-1]
DR   CTD; 6386; -.
DR   DisGeNET; 6386; -.
DR   GeneCards; SDCBP; -.
DR   HGNC; HGNC:10662; SDCBP.
DR   HPA; ENSG00000137575; Low tissue specificity.
DR   MIM; 602217; gene.
DR   neXtProt; NX_O00560; -.
DR   OpenTargets; ENSG00000137575; -.
DR   PharmGKB; PA35592; -.
DR   VEuPathDB; HostDB:ENSG00000137575; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   GeneTree; ENSGT00940000154502; -.
DR   InParanoid; O00560; -.
DR   OMA; QFAQSTA; -.
DR   OrthoDB; 1035679at2759; -.
DR   PhylomeDB; O00560; -.
DR   TreeFam; TF327131; -.
DR   PathwayCommons; O00560; -.
DR   Reactome; R-HSA-3928664; Ephrin signaling.
DR   Reactome; R-HSA-447043; Neurofascin interactions.
DR   Reactome; R-HSA-5213460; RIPK1-mediated regulated necrosis.
DR   Reactome; R-HSA-5675482; Regulation of necroptotic cell death.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; O00560; -.
DR   SIGNOR; O00560; -.
DR   BioGRID-ORCS; 6386; 18 hits in 1079 CRISPR screens.
DR   ChiTaRS; SDCBP; human.
DR   EvolutionaryTrace; O00560; -.
DR   GeneWiki; SDCBP; -.
DR   GenomeRNAi; 6386; -.
DR   Pharos; O00560; Tbio.
DR   PRO; PR:O00560; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; O00560; protein.
DR   Bgee; ENSG00000137575; Expressed in pigmented layer of retina and 208 other tissues.
DR   ExpressionAtlas; O00560; baseline and differential.
DR   Genevisible; O00560; HS.
DR   GO; GO:0005912; C:adherens junction; NAS:UniProtKB.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005856; C:cytoskeleton; NAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:1903561; C:extracellular vesicle; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005895; C:interleukin-5 receptor complex; ISS:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IEA:Ensembl.
DR   GO; GO:0008093; F:cytoskeletal anchor activity; NAS:UniProtKB.
DR   GO; GO:0046875; F:ephrin receptor binding; IEA:Ensembl.
DR   GO; GO:0005109; F:frizzled binding; IPI:BHF-UCL.
DR   GO; GO:0019838; F:growth factor binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005137; F:interleukin-5 receptor binding; ISS:UniProtKB.
DR   GO; GO:0042043; F:neurexin family protein binding; IEA:Ensembl.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0045545; F:syndecan binding; IPI:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; NAS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; NAS:UniProtKB.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0002091; P:negative regulation of receptor internalization; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:UniProtKB.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:UniProtKB.
DR   GO; GO:1903543; P:positive regulation of exosomal secretion; IMP:UniProtKB.
DR   GO; GO:1903553; P:positive regulation of extracellular exosome assembly; IMP:UniProtKB.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IC:BHF-UCL.
DR   GO; GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0099054; P:presynapse assembly; IEA:Ensembl.
DR   GO; GO:0006612; P:protein targeting to membrane; NAS:UniProtKB.
DR   GO; GO:0007265; P:Ras protein signal transduction; IEA:Ensembl.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0006930; P:substrate-dependent cell migration, cell extension; NAS:UniProtKB.
DR   Gene3D; 2.30.42.10; -; 2.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR030528; SDCBP.
DR   PANTHER; PTHR12345:SF10; PTHR12345:SF10; 1.
DR   Pfam; PF00595; PDZ; 2.
DR   SMART; SM00228; PDZ; 2.
DR   SUPFAM; SSF50156; SSF50156; 2.
DR   PROSITE; PS50106; PDZ; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell junction;
KW   Cell membrane; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Endoplasmic reticulum; Lipid-binding; Membrane; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Secreted.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.9, ECO:0007744|PubMed:19413330"
FT   CHAIN           2..298
FT                   /note="Syntenin-1"
FT                   /id="PRO_0000184001"
FT   DOMAIN          114..193
FT                   /note="PDZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          198..273
FT                   /note="PDZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          2..60
FT                   /note="Interaction with PDCD6IP"
FT                   /evidence="ECO:0000269|PubMed:22660413"
FT   MOTIF           3..7
FT                   /note="LYPX(n)L motif 1"
FT                   /evidence="ECO:0000250|UniProtKB:O08992"
FT   MOTIF           45..49
FT                   /note="LYPX(n)L motif 2"
FT                   /evidence="ECO:0000250|UniProtKB:O08992"
FT   MOTIF           49..53
FT                   /note="LYPX(n)L motif 3"
FT                   /evidence="ECO:0000250|UniProtKB:O08992"
FT   BINDING         215
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-4,5-bisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58456"
FT                   /evidence="ECO:0000269|PubMed:27386966,
FT                   ECO:0007744|PDB:4Z33"
FT   BINDING         250..251
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-4,5-bisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58456"
FT                   /evidence="ECO:0000269|PubMed:27386966,
FT                   ECO:0007744|PDB:4Z33"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|Ref.9, ECO:0007744|PubMed:19413330"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         46
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         12..17
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038374"
FT   VAR_SEQ         81
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_038375"
FT   VARIANT         69
FT                   /note="N -> S (in dbSNP:rs1127509)"
FT                   /evidence="ECO:0000269|PubMed:9391086"
FT                   /id="VAR_013160"
FT   MUTAGEN         214
FT                   /note="K->A: Disruption of the cooperative binding of C-
FT                   terminal peptides from FZD7 and phosphatidylinositol-4,5-
FT                   bisphosphate. Impaired interaction with FZD7 and disruption
FT                   of the cooperative binding of C-terminal peptides from FZD7
FT                   and phosphatidylinositol-4,5-bisphosphate; when associated
FT                   with A-250."
FT                   /evidence="ECO:0000269|PubMed:27386966"
FT   MUTAGEN         215
FT                   /note="N->D: Disruption of the cooperative binding of C-
FT                   terminal peptides from FZD7 and phosphatidylinositol-4,5-
FT                   bisphosphate."
FT                   /evidence="ECO:0000269|PubMed:27386966"
FT   MUTAGEN         250
FT                   /note="K->A: Disruption of the cooperative binding of C-
FT                   terminal peptides from FZD7 and phosphatidylinositol-4,5-
FT                   bisphosphate. Impaired interaction with FZD7 and disruption
FT                   of the cooperative binding of C-terminal peptides from FZD7
FT                   and phosphatidylinositol-4,5-bisphosphate; when associated
FT                   with A-214."
FT                   /evidence="ECO:0000269|PubMed:27386966"
FT   CONFLICT        62
FT                   /note="N -> S (in Ref. 2; AAB51246)"
FT                   /evidence="ECO:0000305"
FT   STRAND          113..118
FT                   /evidence="ECO:0007829|PDB:1W9E"
FT   STRAND          121..123
FT                   /evidence="ECO:0007829|PDB:1W9O"
FT   STRAND          126..132
FT                   /evidence="ECO:0007829|PDB:1W9E"
FT   STRAND          135..141
FT                   /evidence="ECO:0007829|PDB:1W9E"
FT   HELIX           146..149
FT                   /evidence="ECO:0007829|PDB:1W9E"
FT   STRAND          157..161
FT                   /evidence="ECO:0007829|PDB:1W9E"
FT   HELIX           171..180
FT                   /evidence="ECO:0007829|PDB:1W9E"
FT   STRAND          183..191
FT                   /evidence="ECO:0007829|PDB:1W9E"
FT   STRAND          197..202
FT                   /evidence="ECO:0007829|PDB:1R6J"
FT   STRAND          205..208
FT                   /evidence="ECO:0007829|PDB:1N99"
FT   STRAND          211..214
FT                   /evidence="ECO:0007829|PDB:1R6J"
FT   STRAND          217..221
FT                   /evidence="ECO:0007829|PDB:1R6J"
FT   HELIX           226..230
FT                   /evidence="ECO:0007829|PDB:1R6J"
FT   STRAND          234..241
FT                   /evidence="ECO:0007829|PDB:1R6J"
FT   HELIX           251..260
FT                   /evidence="ECO:0007829|PDB:1R6J"
FT   STRAND          263..271
FT                   /evidence="ECO:0007829|PDB:1R6J"
FT   HELIX           272..274
FT                   /evidence="ECO:0007829|PDB:4Z33"
SQ   SEQUENCE   298 AA;  32444 MW;  574E1349F86F949F CRC64;
     MSLYPSLEDL KVDKVIQAQT AFSANPANPA ILSEASAPIP HDGNLYPRLY PELSQYMGLS
     LNEEEIRANV AVVSGAPLQG QLVARPSSIN YMVAPVTGND VGIRRAEIKQ GIREVILCKD
     QDGKIGLRLK SIDNGIFVQL VQANSPASLV GLRFGDQVLQ INGENCAGWS SDKAHKVLKQ
     AFGEKITMTI RDRPFERTIT MHKDSTGHVG FIFKNGKITS IVKDSSAARN GLLTEHNICE
     INGQNVIGLK DSQIADILST SGTVVTITIM PAFIFEHIIK RMAPSIMKSL MDHTIPEV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024